DaVita (DVA)
(Delayed Data from NYSE)
$141.55 USD
+1.30 (0.93%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $141.49 -0.06 (-0.04%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth D Momentum A VGM
Price, Consensus and EPS Surprise
DVA 141.55 +1.30(0.93%)
Will DVA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for DVA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DVA
3 Reasons Why You Should Hold McKesson (MCK) Stock for Now
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
DVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Roche Holding's (RHHBY) Accu-Chek SmartGuide Receives CE Mark
Philips (PHG) Gains Despite Recall of SENSE XL Torso Coils
Here's Why You Should Add DaVita (DVA) to Your Portfolio
Other News for DVA
DaVita (DVA) Gets a Hold from Barclays
Long-term beneficiaries of AI, according to Goldman Sachs
What's Driving Agilon Health Inc's Surprising 25% Stock Rally?
IHF: Healthcare Dashboard For June
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway